Clinical Trials Logo
  1. Home
  2. Basal Cell Carcinoma
  3. NCT02125669
  4. Details
NCT02125669 Clinical Trial

Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas

Basal Cell Carcinoma Clinical Trial

Official title:
The Role of the 595 nm Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas at Low Risk Anatomical Sites: Outcome of a Double Blind Randomized Placebo Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02125669
Other study ID # FF57/2012
Secondary ID
Status Completed
Phase N/A
First received April 13, 2014
Last updated April 27, 2014
Start date November 2012
Est. completion date September 2013

Study information
Verified date April 2014
Source Hautklinik Darmstadt
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pulsed dye laser (PDL) treatments have been suggested to be a safe and effective therapeutic approach for treating basal cell carcinomas. Robust supporting evidence is, however, lacking due to inconsistent design of available studies. The purpose of this study is to evaluate the PDL's efficacy and safety in treating superficial basal cell carcinoma (sBCC) at low risk anatomical sites in an evidence based study setting.

Recruitment information / eligibility
Status Completed
Enrollment 100
Est. completion date September 2013
Est. primary completion date September 2013
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- histologically confirmed unpigmented sBCC on the trunk and extremities

- maximal tumour diameter 30 mm

Exclusion Criteria:

- Fitzpatrick skin type >III

- pregnancy

- previous BCC treatment within 4 weeks

- coagulation disorders

- photo sensitizing medication

- any indication of poor compliance

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Laser treatment
Pulsed dye laser 595nm
Device:
• SHAM-Treatment
using the pulsed dye laser (PDL) laser without releasing a pulse

Locations
Country Name City State
n/a

Sponsors (2)
Lead Sponsor Collaborator
Hautklinik Darmstadt University Medicine Greifswald

Outcome
Type Measure Description Time frame Safety issue
Primary complete response 9 months
Secondary patients satisfaction questionnaire 9 months
Secondary side effects questionnaire 9 months
Secondary reduction of tumor diameter and tumor thickness 9 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04552990 - Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma Phase 2
Completed NCT04229277 - Fast Track Diagnosis of Skin Cancer by Advanced Imaging N/A
Completed NCT05608902 - Structural Description of Skin Biopsies With Dynamic Full-field Optical Coherence Tomography on Suspected Basal Cell Carcinoma Lesions, a Pilot Study (DOCTOBA)
Completed NCT05077033 - Intratumoral phIL12 GET Phase 1
Active, not recruiting NCT04928222 - Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) Phase 1/Phase 2
Recruiting NCT04929535 - Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment Phase 2
Completed NCT02662244 - Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma N/A
Completed NCT00959647 - A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study Phase 2
Completed NCT00793169 - Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery
Completed NCT00586040 - Photochemical Tissue Bonding Phase 2
Completed NCT00473343 - Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma Phase 3
Active, not recruiting NCT06024629 - cOCT Versus LC-OCT for Diagnosing Basal Cell Carcinoma: a Diagnostic Cohort Study
Not yet recruiting NCT05324202 - New Imaging Procedures and Therapeutic Approach in Basal Cell Carcinoma Management N/A
Withdrawn NCT04099446 - A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer
Completed NCT02902822 - Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo N/A
Completed NCT01260987 - Fractional CO2 Laser Assisted Photodynamic Therapy Phase 2/Phase 3
Completed NCT01201915 - A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma Phase 2
Completed NCT01208831 - An East Asian Study of LDE225 Phase 1
Completed NCT01014819 - A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions N/A
Completed NCT00472043 - PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Call Carcinoma Phase 3